Jamf Holding JAMF 深 沪
已收盘 12-12 16:00:00 美东时间
13.00
+0.005
+0.04%
华盛通- 最 高13.00
- 今 开12.99
- 成交量 147.91万股
- 最 低 12.99
- 昨 收 12.995
- 总市值 17.29亿
- 52周最高 16.12
- 市盈率 静 --
- 换手率 1.11%
- 52周最低 7.085
- 委 比 -61.91%
- 总股本 1.33亿
- 历史最高 51.00
- 量 比 0.94
- 振 幅 0.08%
- 历史最低 7.085
- 每 手 1
- 风险率 2.30%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Citizens Downgrades Jamf Holding to Market Perform
Citizens analyst Patrick Walravens downgrades Jamf Holding (NASDAQ:JAMF) from Market Outperform to Market Perform.
12-03 23:53
Sprinklr Earnings Preview
Sprinklr (NYSE:CXM) will release its quarterly earnings report on Wednesday, 20...
12-02 23:01
Jamf Partners With UberEther To Pursue FedRAMP High And DoD IL5 Authorization
Jamf (NASDAQ:JAMF), the standard in managing and securing Apple at work, today announced its intent to achieve FedRAMP High and DoD IL5 authorization for United States public sector and commercial organizations requiring
12-02 22:22
Jamf Holding Q3 Adj. EPS $0.25 Beats $0.23 Estimate, Sales $183.494M Beat $177.408M Estimate
Jamf Holding (NASDAQ:JAMF) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $0.23 by 7.76 percent. This is a 56.25 percent increase over earnings of $0.16 per share from the
11-11 05:21
Earnings Scheduled For November 10, 2025
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
11-10 19:12
A Peek at Lightspeed Commerce's Future Earnings
Lightspeed Commerce (NYSE:LSPD) is gearing up to announce its quarterly earning...
11-06 01:01
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
11-04 10:31
美股大行评级 | 最高350美元！16家大行上调谷歌目标价！Meta遭12家大行下调目标价；潜在涨幅1456.29%！NRX Pharmaceuticals获Ascendiant Capital升目标价至47美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从46美元升至47美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从27美元升至31美元
10-31 10:25
Jamf Holding Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
During the last three months, 7 analysts shared their evaluations of Jamf Holdi...
10-30 19:44
美股大行评级 | 275美元！美银证券上调英伟达目标价；花旗上调思佳讯评级至"中性"，目标价从66美元升至91美元
今日重点评级关注：HC Wainwright & Co.：维持Unicycive Therapeutics"买入"评级，目标价从9美元升至22美元；花旗：维持Arcus Biosciences"买入"评级，目标价从54美元升至56美元
10-30 14:22
